Phenotypic profile of alternative activation marker CD163 is different in Alzheimer's and Parkinson's disease

Acta Neuropathologica Communications

Volumn 2, Issue 1, 2014, Pages

  Pey, Peixuan ^a   Pearce, Ronald K B ^a   Kalaitzakis, Michail E ^a   Griffin, W Sue T ^b   Gentleman, Steve M ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Alzheimer's disease; CD163; Inflammation; Microglia; Parkinson's disease; Phagocytosis

Indexed keywords

AIF1 PROTEIN, HUMAN; AMYLOID BETA PROTEIN; CD163 ANTIGEN; CD68 ANTIGEN, HUMAN; CELL SURFACE RECEPTOR; DIFFERENTIATION ANTIGEN; DNA BINDING PROTEIN; FIBRINOGEN; IMMUNOGLOBULIN RECEPTOR; LEUKOCYTE ANTIGEN; MRC1 PROTEIN, HUMAN;

AGED; ALZHEIMER DISEASE; AMYLOID PLAQUE; BRAIN; CELL COUNT; FEMALE; HUMAN; MACROPHAGE; MALE; METABOLISM; MICROGLIA; MIDDLE AGED; NEUROLOGIC EXAMINATION; PARKINSON DISEASE; PATHOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BRAIN; CELL COUNT; DNA-BINDING PROTEINS; FEMALE; FIBRINOGEN; HUMANS; MACROPHAGES; MALE; MICROGLIA; MIDDLE AGED; NEUROLOGIC EXAMINATION; PARKINSON DISEASE; PLAQUE, AMYLOID; RECEPTORS, CELL SURFACE; RECEPTORS, IMMUNOLOGIC;

EID: 84921322562     PISSN: None     EISSN: 20515960     Source Type: Journal    
DOI: 10.1186/2051-5960-2-21     Document Type: Article

References (69)

1. D'Andrea MR, Cole GM, Ard MD: The microglial phagocytic role with specific plaque types in the Alzheimer disease brain. Neurobiol Aging 2004, 25: 675-683. 10.1016/j.neurobiolaging.2003.12.026
2. Hayes A, Thaker U, Iwatsubo T, Pickering-Brown SM, Mann DM: Pathological relationships between microglial cell activity and tau and amyloid beta protein in patients with Alzheimer's disease. Neurosci Lett 2002, 331: 171-174. 10.1016/S0304-3940(02)00888-1
3. Koenigsknecht-Talboo J, Landreth GE: Microglial phagocytosis induced by fibrillar beta-amyloid and IgGs are differentially regulated by proinflammatory cytokines. J Neurosci 2005, 25: 8240-8249. 10.1523/JNEUROSCI.1808-05.2005
4. Kitazawa M, Yamasaki TR, LaFerla FM: Microglia as a potential bridge between the amyloid beta-peptide and tau. Ann N Y Acad Sci 2004, 1035: 85-103. 10.1196/annals.1332.006
5. Beach TG, Sue LI, Walker DG, Lue LF, Connor DJ, Caviness JN, et al.: Marked microglial reaction in normal aging human substantia nigra: correlation with extraneuronal neuromelanin pigment deposits. Acta Neuropathol 2007, 114: 419-424. 10.1007/s00401-007-0250-5
6. Zecca L, Zucca FA, Albertini A, Rizzio E, Fariello RG: A proposed dual role of neuromelanin in the pathogenesis of Parkinson's disease. Neurology 2006, 67: S8-S11. 10.1212/WNL.67.7_suppl_2.S8
7. Park JY, Paik SR, Jou I, Park SM: Microglial phagocytosis is enhanced by monomeric alpha-synuclein, not aggregated alpha-synuclein: implications for Parkinson's disease. Glia 2008, 56: 1215-1223. 10.1002/glia.20691
8. Knott C, Stern G, Kingsbury A, Welcher AA, Wilkin GP: Elevated glial brain-derived neurotrophic factor in Parkinson's diseased nigra. Parkinsonism Relat Disord 2002, 8: 329-341. 10.1016/S1353-8020(02)00008-1
9. Lue LF, Kuo YM, Beach T, Walker DG: Microglia activation and anti-inflammatory regulation in Alzheimer's disease. Mol Neurobiol 2010, 41: 115-128. 10.1007/s12035-010-8106-8
10. Maccioni RB, Rojo LE, Fernandez JA, Kuljis RO: The role of neuroimmunomodulation in Alzheimer's disease. Ann N Y Acad Sci 2009, 1153: 240-246. 10.1111/j.1749-6632.2008.03972.x
11. Farooqui T, Farooqui AA: Lipid-mediated oxidative stress and inflammation in the pathogenesis of Parkinson's disease. Parkinsons Dis 2011, 2011: 247467.
12. Qian L, Flood PM: Microglial cells and Parkinson's disease. Immunol Res 2008, 41: 155-164. 10.1007/s12026-008-8018-0
13. Johnston H, Boutin H, Allan SM: Assessing the contribution of inflammation in models of Alzheimer's disease. Biochem Soc Trans 2011, 39: 886-890. 10.1042/BST0390886
14. Kettenmann H, Hanisch UK, Noda M, Verkhratsky A: Physiology of microglia. Physiol Rev 2011, 91: 461-553. 10.1152/physrev.00011.2010
15. Mrak RE, Griffin WS: Interleukin-1, neuroinflammation, and Alzheimer's disease. Neurobiol Aging 2001, 22: 903-908. 10.1016/S0197-4580(01)00287-1
16. Porcheray F, Viaud S, Rimaniol AC, Leone C, Samah B, Dereuddre-Bosquet N, et al.: Macrophage activation switching: an asset for the resolution of inflammation. Clin Exp Immunol 2005, 142: 481-489.
17. Gordon S: Alternative activation of macrophages. Nat Rev Immunol 2003, 3: 23-35. 10.1038/nri978
18. Colton CA, Mott RT, Sharpe H, Xu Q, Van Nostrand WE, Vitek MP: Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD. J Neuroinflammation 2006, 3: 27. 10.1186/1742-2094-3-27
19. El Khoury J, Luster AD: Mechanisms of microglia accumulation in Alzheimer's disease: therapeutic implications. Trends Pharmacol Sci 2008, 29: 626-632. 10.1016/j.tips.2008.08.004
20. Colton CA, Wilcock DM: Assessing activation states in microglia. CNS Neurol Disord Drug Targets 2010, 9: 174-191. 10.2174/187152710791012053
21. Griffin WS: Inflammation and neurodegenerative diseases. Am J Clin Nutr 2006, 83: 470S-474S.
22. Hickman SE, Allison EK, El Khoury J: Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice. J Neurosci 2008, 28: 8354-8360. 10.1523/JNEUROSCI.0616-08.2008
23. Saha RN, Ghosh A, Palencia CA, Fung YK, Dudek SM, Pahan K: TNF-alpha preconditioning protects neurons via neuron-specific up-regulation of CREB-binding protein. J Immunol 2009, 183: 2068-2078. 10.4049/jimmunol.0801892
24. Perry VH, Nicoll JA, Holmes C: Microglia in neurodegenerative disease. Nat Rev Neurol 2010, 6: 193-201. 10.1038/nrneurol.2010.17
25. Fiala M, Liu QN, Sayre J, Pop V, Brahmandam V, Graves MC, et al.: Cyclooxygenase-2-positive macrophages infiltrate the Alzheimer's disease brain and damage the blood-brain barrier. Eur J Clin Invest 2002, 32: 360-371. 10.1046/j.1365-2362.2002.00994.x
26. Gate D, Rezai-Zadeh K, Jodry D, Rentsendorj A, Town T: Macrophages in Alzheimer's disease: the blood-borne identity. J Neural Transm 2010, 117: 961-970. 10.1007/s00702-010-0422-7
27. Malm TM, Magga J, Kuh GF, Vatanen T, Koistinaho M, Koistinaho J: Minocycline reduces engraftment and activation of bone marrow-derived cells but sustains their phagocytic activity in a mouse model of Alzheimer's disease. Glia 2008, 56: 1767-1779. 10.1002/glia.20726
28. Simard AR, Soulet D, Gowing G, Julien JP, Rivest S: Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron 2006, 49: 489-502. 10.1016/j.neuron.2006.01.022
29. Hawkes CA, McLaurin J: Selective targeting of perivascular macrophages for clearance of beta-amyloid in cerebral amyloid angiopathy. Proc Natl Acad Sci U S A 2009, 106: 1261-1266. 10.1073/pnas.0805453106
30. Zaghi J, Goldenson B, Inayathullah M, Lossinsky AS, Masoumi A, Avagyan H, et al.: Alzheimer disease macrophages shuttle amyloid-beta from neurons to vessels, contributing to amyloid angiopathy. Acta Neuropathol 2009, 117: 111-124. 10.1007/s00401-008-0481-0
31. Fabriek BO, Van Haastert ES, Galea I, Polfliet MM, Dopp ED, Van Den Heuvel MM, et al.: CD163-positive perivascular macrophages in the human CNS express molecules for antigen recognition and presentation. Glia 2005, 51: 297-305. 10.1002/glia.20208
32. Graversen JH, Madsen M, Moestrup SK: CD163: a signal receptor scavenging haptoglobin-hemoglobin complexes from plasma. Int J Biochem Cell Biol 2002, 34: 309-314. 10.1016/S1357-2725(01)00144-3
33. Kim WK, Alvarez X, Fisher J, Bronfin B, Westmoreland S, McLaurin J, et al.: CD163 identifies perivascular macrophages in normal and viral encephalitic brains and potential precursors to perivascular macrophages in blood. Am J Pathol 2006, 168: 822-834. 10.2353/ajpath.2006.050215
34. Lau SK, Chu PG, Weiss LM: CD163: a specific marker of macrophages in paraffin-embedded tissue samples. Am J Clin Pathol 2004, 122: 794-801. 10.1309/QHD6YFN81KQXUUH6
35. Schaer DJ, Alayash AI, Buehler PW: Gating the radical hemoglobin to macrophages: the anti-inflammatory role of CD163, a scavenger receptor. Antioxid Redox Signal 2007, 9: 991-999. 10.1089/ars.2007.1576
36. Fabriek BO, van Bruggen R, Deng DM, Ligtenberg AJ, Nazmi K, Schornagel K, et al.: The macrophage scavenger receptor CD163 functions as an innate immune sensor for bacteria. Blood 2009, 113: 887-892. 10.1182/blood-2008-07-167064
37. Alafuzoff I, Arzberger T, Al-Sarraj S, Bodi I, Bogdanovic N, Braak H, et al.: Staging of neurofibrillary pathology in Alzheimer's disease: a study of the BrainNet Europe Consortium. Brain Pathol 2008, 18: 484-496.
38. Alafuzoff I, Ince PG, Arzberger T, Al-Sarraj S, Bell J, Bodi I, et al.: Staging/typing of Lewy body related alpha-synuclein pathology: a study of the BrainNet Europe Consortium. Acta Neuropathol 2009, 117: 635-652. 10.1007/s00401-009-0523-2
39. McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, et al.: Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005, 65: 1863-1872. 10.1212/01.wnl.0000187889.17253.b1
40. Borda JT, Alvarez X, Mohan M, Hasegawa A, Bernardino A, Jean S, et al.: CD163, a marker of perivascular macrophages, is up-regulated by microglia in simian immunodeficiency virus encephalitis after haptoglobin-hemoglobin complex stimulation and is suggestive of breakdown of the blood-brain barrier. Am J Pathol 2008, 172: 725-737. 10.2353/ajpath.2008.070848
41. Roberts ES, Masliah E, Fox HS: CD163 identifies a unique population of ramified microglia in HIV encephalitis (HIVE). J Neuropathol Exp Neurol 2004, 63: 1255-1264.
42. Gentleman SM, Leclercq PD, Moyes L, Graham DI, Smith C, Griffin WS, et al.: Long-term intracerebral inflammatory response after traumatic brain injury. Forensic Sci Int 2004, 146: 97-104. 10.1016/j.forsciint.2004.06.027
43. Fan R, Xu F, Previti ML, Davis J, Grande AM, Robinson JK, et al.: Minocycline reduces microglial activation and improves behavioral deficits in a transgenic model of cerebral microvascular amyloid. J Neurosci 2007, 27: 3057-3063. 10.1523/JNEUROSCI.4371-06.2007
44. Lue LF, Walker DG, Rogers J: Modeling microglial activation in Alzheimer's disease with human postmortem microglial cultures. Neurobiol Aging 2001, 22: 945-956. 10.1016/S0197-4580(01)00311-6
45. Croisier E, Moran LB, Dexter DT, Pearce RK, Graeber MB: Microglial inflammation in the parkinsonian substantia nigra: relationship to alpha-synuclein deposition. J Neuroinflammation 2005, 2: 14. 10.1186/1742-2094-2-14
46. Ouchi Y, Yagi S, Yokokura M, Sakamoto M: Neuroinflammation in the living brain of Parkinson's disease. Parkinsonism Relat Disord 2009, 15(Suppl 3):S200-S204.
47. Walker DG, Dalsing-Hernandez JE, Campbell NA, Lue LF: Decreased expression of CD200 and CD200 receptor in Alzheimer's disease: a potential mechanism leading to chronic inflammation. Exp Neurol 2009, 215: 5-19. 10.1016/j.expneurol.2008.09.003
48. Zotova E, Holmes C, Johnston D, Neal JW, Nicoll JA, Boche D: Microglial alterations in human Alzheimer's disease following Abeta42 immunization. Neuropathol Appl Neurobiol 2011, 37: 513-524. 10.1111/j.1365-2990.2010.01156.x
49. Hogger P, Dreier J, Droste A, Buck F, Sorg C: Identification of the integral membrane protein RM3/1 on human monocytes as a glucocorticoid-inducible member of the scavenger receptor cysteine-rich family (CD163). J Immunol 1998, 161: 1883-1890.
50. Van den Heuvel MM, Tensen CP, van As JH, Van den Berg TK, Fluitsma DM, Dijkstra CD, et al.: Regulation of CD 163 on human macrophages: cross-linking of CD163 induces signaling and activation. J Leukoc Biol 1999, 66: 858-866.
51. Wenzel I, Roth J, Sorg C: Identification of a novel surface molecule, RM3/1, that contributes to the adhesion of glucocorticoid-induced human monocytes to endothelial cells. Eur J Immunol 1996, 26: 2758-2763. 10.1002/eji.1830261131
52. Zwadlo-Klarwasser G, Bent S, Haubeck HD, Sorg C, Schmutzler W: Glucocorticoid-induced appearance of the macrophage subtype RM 3/1 in peripheral blood of man. Int Arch Allergy Appl Immunol 1990, 91: 175-180. 10.1159/000235111
53. Ritter M, Buechler C, Langmann T, Schmitz G: Genomic organization and chromosomal localization of the human CD163 (M130) gene: a member of the scavenger receptor cysteine-rich superfamily. Biochem Biophys Res Commun 1999, 260: 466-474. 10.1006/bbrc.1999.0866
54. Weaver LK, Pioli PA, Wardwell K, Vogel SN, Guyre PM: Up-regulation of human monocyte CD163 upon activation of cell-surface Toll-like receptors. J Leukoc Biol 2007, 81: 663-671.
55. Buechler C, Ritter M, Orso E, Langmann T, Klucken J, Schmitz G: Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuli. J Leukoc Biol 2000, 67: 97-103.
56. Pioli PA, Goonan KE, Wardwell K, Guyre PM: TGF-beta regulation of human macrophage scavenger receptor CD163 is Smad3-dependent. J Leukoc Biol 2004, 76: 500-508. 10.1189/jlb.1203617
57. Sulahian TH, Hogger P, Wahner AE, Wardwell K, Goulding NJ, Sorg C, et al.: Human monocytes express CD163, which is upregulated by IL-10 and identical to p155. Cytokine 2000, 12: 1312-1321. 10.1006/cyto.2000.0720
58. Holmes C, Boche D, Wilkinson D, Yadegarfar G, Hopkins V, Bayer A, et al.: Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial. Lancet 2008, 372: 216-223. 10.1016/S0140-6736(08)61075-2
59. Galea I, Palin K, Newman TA, Van Rooijen N, Perry VH, Boche D: Mannose receptor expression specifically reveals perivascular macrophages in normal, injured, and diseased mouse brain. Glia 2005, 49: 375-384. 10.1002/glia.20124
60. Musiani S, Battelli MG: Mannose receptor determination by an ELISA-like method. J Biochem Biophys Methods 2003, 55: 121-125. 10.1016/S0165-022X(03)00019-8
61. Eikelenboom P, Veerhuis R, Scheper W, Rozemuller AJ, van Gool WA, Hoozemans JJ: The significance of neuroinflammation in understanding Alzheimer's disease. J Neural Transm 2006, 113: 1685-1695. 10.1007/s00702-006-0575-6
62. Ito D, Tanaka K, Suzuki S, Dembo T, Fukuuchi Y: Enhanced expression of Iba1, ionized calcium-binding adapter molecule 1, after transient focal cerebral ischemia in rat brain. Stroke 2001, 32: 1208-1215. 10.1161/01.STR.32.5.1208
63. Kanazawa H, Ohsawa K, Sasaki Y, Kohsaka S, Imai Y: Macrophage/microglia-specific protein Iba1 enhances membrane ruffling and Rac activation via phospholipase C-gamma -dependent pathway. J Biol Chem 2002, 277: 20026-20032. 10.1074/jbc.M109218200
64. Ahmed Z, Shaw G, Sharma VP, Yang C, McGowan E, Dickson DW: Actin-binding proteins coronin-1a and IBA-1 are effective microglial markers for immunohistochemistry. J Histochem Cytochem 2007, 55: 687-700. 10.1369/jhc.6A7156.2007
65. Mendes-Jorge L, Ramos D, Luppo M, Llombart C, Alexandre-Pires G, Nacher V, et al.: Scavenger function of resident autofluorescent perivascular macrophages and their contribution to the maintenance of the blood-retinal barrier. Invest Ophthalmol Vis Sci 2009, 50: 5997-6005. 10.1167/iovs.09-3515
66. Xu H, Chen M, Mayer EJ, Forrester JV, Dick AD: Turnover of resident retinal microglia in the normal adult mouse. Glia 2007, 55: 1189-1198. 10.1002/glia.20535
67. Perry VH: The influence of systemic inflammation on inflammation in the brain: implications for chronic neurodegenerative disease. Brain Behav Immun 2004, 18: 407-413. 10.1016/j.bbi.2004.01.004
68. Tansey MG, Goldberg MS: Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention. Neurobiol Dis 2010, 37: 510-518. 10.1016/j.nbd.2009.11.004
69. Whitton PS: Inflammation as a causative factor in the aetiology of Parkinson's disease. Br J Pharmacol 2007, 150: 963-976.